1
|
Bouare N, Delwaide J. Interleukin-mediated therapies in liver diseases and comorbidity effects. World J Hepatol 2024; 16:980-989. [PMID: 39086534 PMCID: PMC11287617 DOI: 10.4254/wjh.v16.i7.980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Revised: 05/13/2024] [Accepted: 05/17/2024] [Indexed: 07/26/2024] Open
Abstract
Cytokines like interleukins (ILs) play important roles in inflammation and innate immune. Yang and Zhang carried out an interesting study related to ILs and hepatic diseases. They described the role of ILs in the pathogenesis and resolution of hepatic disorders. The authors summarized alcohol-related liver disease and virus-induced hepatitis, as far as clinical studies a fortiori carried out on IL-mediated treatments pertaining to these dysfunctions. This editorial contributes to the review by Yang and Zhang titled, "Interleukins in liver disease treatment", and focuses on therapies mediated by ILs in comorbid liver diseases. The documentary search was conducted on recent pertinent literature, primarily using the Google Scholar and PubMed databases.
Collapse
Affiliation(s)
- Nouhoum Bouare
- Department of Quality, Hygien, Biosafety/Biosecurity and Pharmacovigilence, National Institute of Public Health, Bamako 1771, Mali.
| | - Jean Delwaide
- Department of Gastroenterology and Hepatology, CHULiege, Liege 4000, Belgium
| |
Collapse
|
2
|
Passos-Silva AM, Silva EDCE, Borzacov LMP, Araújo A, Porto AS, Salcedo JMV, Vieira D. Molecular genetic association of rs8099917 and rs1800795 polymorphisms in the progression of hepatitis Delta virus liver disease. J Venom Anim Toxins Incl Trop Dis 2024; 30:e20230025. [PMID: 38221914 PMCID: PMC10786575 DOI: 10.1590/1678-9199-jvatitd-2023-0025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Accepted: 11/23/2023] [Indexed: 01/16/2024] Open
Abstract
Background The relationship between viral infections and host factors holds high hopes for identifying the role of Interferon Lambda 3 (IFNL3) and Interleukin 6 (IL-6) polymorphisms in the development of Chronic Liver Disease (CLD) in patients infected with hepatitis Delta virus (HDV) in the Western Brazilian Amazon. Methods Cross-sectional study conducted with a cohort of 40 chronic HDV patients, 27 with CLD and 13 without evident liver damage. Biological samples from the participants were analyzed using the polymerase chain reaction (PCR) technique, followed by sequencing by the automated Sanger method. Results The rs8099917 T allele, from the IFNL3 gene, showed a higher frequency in both groups; however, it was not possible to establish an association with HDV infection [OR = 1.42 (0.42 - 4.75; p = 0.556 (95% CI). For IL-6, the rs1800795 G allele was superior to rs1800795 C. Analyzing both distributions in the studied groups, any association with HDV was absent (p > 0.05). Conclusion The results suggest that the rs8099917 T/G (IFNL3) and rs1800795 G/C (IL-6) polymorphisms are not associated with the evolution of HDV in the studied population.
Collapse
Affiliation(s)
- Ana Maísa Passos-Silva
- Molecular Virology Laboratory, Oswaldo Cruz Foundation Rondonia -
FIOCRUZ/RO, Porto Velho, RO, Brazil
- Postgraduate Program in Experimental Biology, Federal University of
Rondonia, UNIR/FIOCRUZ-RO, Porto Velho, RO, Brazil
- Tropical Medicine Research Center - CEPEM, Porto Velho, RO,
Brazil
- National Institute of Epidemiology of the Western Amazon, INCT
EpiAmO, Porto Velho, RO, Brazil
| | | | | | - Adrhyan Araújo
- Molecular Virology Laboratory, Oswaldo Cruz Foundation Rondonia -
FIOCRUZ/RO, Porto Velho, RO, Brazil
- Tropical Medicine Research Center - CEPEM, Porto Velho, RO,
Brazil
- National Institute of Epidemiology of the Western Amazon, INCT
EpiAmO, Porto Velho, RO, Brazil
| | - Anita Sperandio Porto
- Federal University of Rondonia, UNIR, Porto Velho, RO,
Brazil
- Unir Pathology Laboratory, UNIR/RO, Porto Velho, RO, Brazil
| | - Juan Miguel Villalobos Salcedo
- Federal University of Rondonia, UNIR, Porto Velho, RO,
Brazil
- Tropical Medicine Research Center - CEPEM, Porto Velho, RO,
Brazil
- National Institute of Epidemiology of the Western Amazon, INCT
EpiAmO, Porto Velho, RO, Brazil
| | - Deusilene Vieira
- Molecular Virology Laboratory, Oswaldo Cruz Foundation Rondonia -
FIOCRUZ/RO, Porto Velho, RO, Brazil
- Postgraduate Program in Experimental Biology, Federal University of
Rondonia, UNIR/FIOCRUZ-RO, Porto Velho, RO, Brazil
- Tropical Medicine Research Center - CEPEM, Porto Velho, RO,
Brazil
- National Institute of Epidemiology of the Western Amazon, INCT
EpiAmO, Porto Velho, RO, Brazil
| |
Collapse
|
3
|
Carriazo S, Abasheva D, Duarte D, Ortiz A, Sanchez-Niño MD. SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific Therapies. Int J Mol Sci 2023; 24:16078. [PMID: 38003268 PMCID: PMC10671056 DOI: 10.3390/ijms242216078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2023] [Revised: 10/29/2023] [Accepted: 11/06/2023] [Indexed: 11/26/2023] Open
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which has killed ~7 million persons worldwide. Chronic kidney disease (CKD) is the most common risk factor for severe COVID-19 and one that most increases the risk of COVID-19-related death. Moreover, CKD increases the risk of acute kidney injury (AKI), and COVID-19 patients with AKI are at an increased risk of death. However, the molecular basis underlying this risk has not been well characterized. CKD patients are at increased risk of death from multiple infections, to which immune deficiency in non-specific host defenses may contribute. However, COVID-19-associated AKI has specific molecular features and CKD modulates the local (kidney) and systemic (lung, aorta) expression of host genes encoding coronavirus-associated receptors and factors (SCARFs), which SARS-CoV-2 hijacks to enter cells and replicate. We review the interaction between kidney disease and COVID-19, including the over 200 host genes that may influence the severity of COVID-19, and provide evidence suggesting that kidney disease may modulate the expression of SCARF genes and other key host genes involved in an effective adaptive defense against coronaviruses. Given the poor response of certain CKD populations (e.g., kidney transplant recipients) to SARS-CoV-2 vaccines and their suboptimal outcomes when infected, we propose a research agenda focusing on CKD to develop the concept of comorbidity-specific targeted therapeutic approaches to SARS-CoV-2 infection or to future coronavirus infections.
Collapse
Affiliation(s)
- Sol Carriazo
- Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, Toronto, ON M5G 2C4, Canada;
- RICORS2040, 28049 Madrid, Spain;
| | - Daria Abasheva
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, 28049 Madrid, Spain; (D.A.); (D.D.)
| | - Deborah Duarte
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, 28049 Madrid, Spain; (D.A.); (D.D.)
| | - Alberto Ortiz
- RICORS2040, 28049 Madrid, Spain;
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, 28049 Madrid, Spain; (D.A.); (D.D.)
- Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Madrid, 28049 Madrid, Spain
| | - Maria Dolores Sanchez-Niño
- RICORS2040, 28049 Madrid, Spain;
- Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, 28049 Madrid, Spain; (D.A.); (D.D.)
- Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, 28049 Madrid, Spain
| |
Collapse
|